SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-025566
Filing Date
2024-03-25
Accepted
2024-03-25 16:33:05
Documents
5
Effectiveness Date
2024-03-25

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0202343-s8_allarity.htm S-8 85782
2 OPINION OF VENABLE LLP ea020234301ex5-1_allarity.htm EX-5.1 6051
3 CONSENT OF WOLF & COMPANY, P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea020234301ex23-2_allarity.htm EX-23.2 1802
4 FILING FEE TABLE ea020234301ex-fee_allarity.htm EX-FILING FEES 15105
5 GRAPHIC ex5-1_001.jpg GRAPHIC 25967
  Complete submission text file 0001213900-24-025566.txt   145665
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278214 | Film No.: 24779689
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)